DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Hilton Lac-Leamy

2026年10月26日 (月) 午前 7:30 - 2026年10月27日 (火) 午後 4:00

3 Boulevard du Casino, Gatineau, QC J8Y 6X4, Canada

Canada Annual Meeting

The Canada Annual Meeting offers three tracks, Regulatory, Clinical, Safety and Pharmacovigilance!

Early Bird Ends

DAYS

HOURS

MINUTES

SECONDS

ハイライト&特長

What is happening at Canada Annual Meeting



Need Approval in Order to Attend?

Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.



  • Bring together regulators, industry, patients, and academia to exchange perspectives on Canada’s role in global regulatory science
  • Highlight the latest developments in regulation, safety, labeling, trial modernization, and digital transformation
  • Strengthen partnerships between Health Canada, international regulators, industry leaders, and patient representatives
  • Provide learning opportunities across regulatory, clinical, and safety domains to expand participant knowledge and expertise
  • Create space for peer-to-peer exchange through plenaries, breakouts, and dedicated networking sessions

  • Direct access to Health Canada leadership and global regulators
  • Timely updates on evolving regulations, policies, and compliance frameworks
  • Patient-centered perspectives that put lived experience at the heart of discussions
  • Cutting-edge insights on AI, digital submissions, and innovative clinical research models
  • Opportunities to connect with diverse stakeholders across the life sciences ecosystem


Three Educational Tracks: Regulatory, Clinical, Safety and Pharmacovigilance


Track A: Regulatory

The regulatory track provides opportunities for information sharing, use cases, and best practices relating to Canada’s regulatory landscape as it applies to regulatory requirements, new developments, and innovation for life sciences R&D.

Track B: Clinical

Today, modern pharmaceutical, medical device, and diagnostic products are advancing at an unprecedented speed. Sessions in this track will focus on clinical research development and operations for industry.

Track C: Safety and Pharmacovigilance

Our safety and pharmacovigilance track will provide a comprehensive overview of Canada’s regulatory environment in the field of clinical safety and pharmacovigilance for pharmaceutical products and medical devices.

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。